Clinical Trials & Pipeline
News & Events
Mirna is a clinical stage biopharmaceutical company developing a broad pipeline of leading microRNA-based oncology therapeutics, the first to be tested in cancer patients.
LEARN MORE ABOUT US
MRX34, Mirna’s lead product candidate, is the first microRNA mimic to enter clinical testing.
LEARN MORE ABOUT OUR CLINICAL TRIALS AND PIPELINE
September 26, 2014
Mirna Therapeutics Inc. Announces Scientific Publication that Outlines a Combinatorial microRNA Approach in Preclinical Lung Cancer Model
September 15, 2014
Mirna Therapeutics Inc. Appoints Lawrence M. Alleva to Its Board of Directors
VIEW ALL NEWS
© 2014 Mirna Therapeutics, Inc. All Rights Reserved.